Recursion Pharmaceuticals a Aktie
WKN DE: A3CM1C / ISIN: US75629V1044
28.02.2025 13:06:27
|
Recursion Posts Wider Loss In Q4 - Quick Facts
(RTTNews) - Recursion (RXRX) posted a net loss of $178.9 million for the fourth quarter of 2024, compared to a net loss of $93.0 million for the fourth quarter of 2023. Net loss per share was $0.53 compared to a loss of $0.42. Analysts on average had expected the company to post a loss of $0.42 per share. Analysts' estimates typically exclude special items.
Fourth quarter total revenue, consisting primarily of revenue from collaborative agreements, was $4.5 million, compared to $10.9 million for the fourth quarter of 2023.
Shares of Recursion are down 10% in pre-market trade on Friday.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Recursion Pharmaceuticals, Inc Registered Shs -A-mehr Nachrichten
27.02.25 |
Ausblick: Recursion Pharmaceuticals, A präsentiert das Zahlenwerk zum abgelaufenen Jahresviertel (finanzen.net) |